在常规护理中实施无模拟放疗 (SFRT) 快速缓解:对 SFRT-1000 队列的倾向得分加权调整分析

{"title":"在常规护理中实施无模拟放疗 (SFRT) 快速缓解:对 SFRT-1000 队列的倾向得分加权调整分析","authors":"","doi":"10.1016/j.ijrobp.2024.07.033","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose/Objective(s)</h3><div>The feasibility of simulation-free radiotherapy (SFRT) has been demonstrated but information regarding its impact on routine care is lacking. The hypothesis was that SFRT is scaleable and beneficial in routine care. Key endpoints of this single institution study were SFRT utilization, impact on consultation-to-RT time and on-couch treatment duration.</div></div><div><h3>Materials/Methods</h3><div>All patients receiving palliative RT in the study period were eligible for consideration of SFRT unless mask immobilization, a stereotactic technique, or a definitive dose was required. Timing metrics were compared to a contemporary local cohort that received simulation-based palliative RT using unadjusted medians (Wilcoxon rank-sum test) and a propensity score-weighted regression. Electronic patient-reported outcomes (ePROs) captured 2-week toxicity and pain response.</div></div><div><h3>Results</h3><div>Between April 2018 and February 2024, there were 2845 palliative radiation courses were delivered, of which 1904 were eligible for this study. One thousand of the 1904 courses (52.5% SFRT utilization) were treated using the SFRT protocol, including 668 with IMRT/VMAT. Median patient age was 71 years with 60% being male and 32% being ECOG 2-4. SFRT reduced median consultation-to-RT time from 7.0 to 5.1 days (<em>P</em> &lt; 0.0001) corresponding to an adjusted average treatment effect (aATE) of -2.3 days (95% CI = -2.9 to -1.7). SFRT increased median on-couch treatment duration from 16 min to 18 min (<em>P</em> &lt; 0.0001; aATE 2.0 min, 95% CI = 0.2 to 3.9). SFRT utilization in eligible courses increased from 41% to 54% between the years 2018 and 2019 and 2022 and 2024. PRO-CTCAE grade 3 acute toxicity was 9% and at 4 weeks post RT patients with moderate/severe pain at baseline (≥ 5/10) had had a mean pain reduction of 3.5 points (7.1 to 3.6).</div></div><div><h3>Conclusion</h3><div>Using widely available technologies the SFRT-1000 cohort demonstrates routine care scalability with patient-centered and workflow benefits. SFRT is an attractive new palliative RT paradigm implementable in most settings.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":null,"pages":null},"PeriodicalIF":6.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Implementing Simulation-Free Radiotherapy (SFRT) Rapid Access Palliation in Routine Care: A Propensity Score Weight-Adjusted Analysis of the SFRT-1000 Cohort\",\"authors\":\"\",\"doi\":\"10.1016/j.ijrobp.2024.07.033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose/Objective(s)</h3><div>The feasibility of simulation-free radiotherapy (SFRT) has been demonstrated but information regarding its impact on routine care is lacking. The hypothesis was that SFRT is scaleable and beneficial in routine care. Key endpoints of this single institution study were SFRT utilization, impact on consultation-to-RT time and on-couch treatment duration.</div></div><div><h3>Materials/Methods</h3><div>All patients receiving palliative RT in the study period were eligible for consideration of SFRT unless mask immobilization, a stereotactic technique, or a definitive dose was required. Timing metrics were compared to a contemporary local cohort that received simulation-based palliative RT using unadjusted medians (Wilcoxon rank-sum test) and a propensity score-weighted regression. Electronic patient-reported outcomes (ePROs) captured 2-week toxicity and pain response.</div></div><div><h3>Results</h3><div>Between April 2018 and February 2024, there were 2845 palliative radiation courses were delivered, of which 1904 were eligible for this study. One thousand of the 1904 courses (52.5% SFRT utilization) were treated using the SFRT protocol, including 668 with IMRT/VMAT. Median patient age was 71 years with 60% being male and 32% being ECOG 2-4. SFRT reduced median consultation-to-RT time from 7.0 to 5.1 days (<em>P</em> &lt; 0.0001) corresponding to an adjusted average treatment effect (aATE) of -2.3 days (95% CI = -2.9 to -1.7). SFRT increased median on-couch treatment duration from 16 min to 18 min (<em>P</em> &lt; 0.0001; aATE 2.0 min, 95% CI = 0.2 to 3.9). SFRT utilization in eligible courses increased from 41% to 54% between the years 2018 and 2019 and 2022 and 2024. PRO-CTCAE grade 3 acute toxicity was 9% and at 4 weeks post RT patients with moderate/severe pain at baseline (≥ 5/10) had had a mean pain reduction of 3.5 points (7.1 to 3.6).</div></div><div><h3>Conclusion</h3><div>Using widely available technologies the SFRT-1000 cohort demonstrates routine care scalability with patient-centered and workflow benefits. SFRT is an attractive new palliative RT paradigm implementable in most settings.</div></div>\",\"PeriodicalId\":14215,\"journal\":{\"name\":\"International Journal of Radiation Oncology Biology Physics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.4000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology Biology Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0360301624007958\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624007958","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的/目标:无模拟放疗(SFRT)的可行性已得到证实,但有关其对常规治疗的影响的信息还很缺乏。我们的假设是,无模拟放疗可在常规治疗中推广并产生效益。材料/方法在研究期间接受姑息性 RT 的所有患者都有资格考虑使用 SFRT,除非需要面罩固定、立体定向技术或确定剂量。采用未调整中位数(Wilcoxon秩和检验)和倾向得分加权回归法,将时间指标与接受模拟姑息性 RT 的当代当地队列进行比较。电子患者报告结果(ePRO)记录了2周毒性和疼痛反应。结果2018年4月至2024年2月期间,共进行了2845个姑息性放射疗程,其中1904个疗程符合本研究的条件。1904个疗程中有1000个疗程(52.5%使用了SFRT)使用了SFRT方案,其中668个疗程使用了IMRT/VMAT。患者年龄中位数为 71 岁,60% 为男性,32% 为 ECOG 2-4 级。SFRT将从就诊到RT的中位时间从7.0天缩短至5.1天(P < 0.0001),相应的调整后平均治疗效果(aATE)为-2.3天(95% CI = -2.9至-1.7)。SFRT 可将中位治疗时间从 16 分钟延长至 18 分钟(P < 0.0001;aATE 2.0 分钟,95% CI = 0.2 至 3.9)。2018年至2019年以及2022年至2024年期间,符合条件的疗程中SFRT的使用率从41%增至54%。PRO-CTCAE3级急性毒性为9%,在RT后4周,基线中度/重度疼痛(≥5/10)患者的平均疼痛减轻了3.5点(7.1至3.6)。SFRT 是一种极具吸引力的新型姑息性 RT 范例,可在大多数情况下实施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Implementing Simulation-Free Radiotherapy (SFRT) Rapid Access Palliation in Routine Care: A Propensity Score Weight-Adjusted Analysis of the SFRT-1000 Cohort

Purpose/Objective(s)

The feasibility of simulation-free radiotherapy (SFRT) has been demonstrated but information regarding its impact on routine care is lacking. The hypothesis was that SFRT is scaleable and beneficial in routine care. Key endpoints of this single institution study were SFRT utilization, impact on consultation-to-RT time and on-couch treatment duration.

Materials/Methods

All patients receiving palliative RT in the study period were eligible for consideration of SFRT unless mask immobilization, a stereotactic technique, or a definitive dose was required. Timing metrics were compared to a contemporary local cohort that received simulation-based palliative RT using unadjusted medians (Wilcoxon rank-sum test) and a propensity score-weighted regression. Electronic patient-reported outcomes (ePROs) captured 2-week toxicity and pain response.

Results

Between April 2018 and February 2024, there were 2845 palliative radiation courses were delivered, of which 1904 were eligible for this study. One thousand of the 1904 courses (52.5% SFRT utilization) were treated using the SFRT protocol, including 668 with IMRT/VMAT. Median patient age was 71 years with 60% being male and 32% being ECOG 2-4. SFRT reduced median consultation-to-RT time from 7.0 to 5.1 days (P < 0.0001) corresponding to an adjusted average treatment effect (aATE) of -2.3 days (95% CI = -2.9 to -1.7). SFRT increased median on-couch treatment duration from 16 min to 18 min (P < 0.0001; aATE 2.0 min, 95% CI = 0.2 to 3.9). SFRT utilization in eligible courses increased from 41% to 54% between the years 2018 and 2019 and 2022 and 2024. PRO-CTCAE grade 3 acute toxicity was 9% and at 4 weeks post RT patients with moderate/severe pain at baseline (≥ 5/10) had had a mean pain reduction of 3.5 points (7.1 to 3.6).

Conclusion

Using widely available technologies the SFRT-1000 cohort demonstrates routine care scalability with patient-centered and workflow benefits. SFRT is an attractive new palliative RT paradigm implementable in most settings.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
期刊最新文献
A Phase I Trial of Image-Guided, Risk-Volume-Adapted Post-Prostatectomy Radiotherapy. ORAI2 is Important for the Development of Early-Stage Post-Irradiation Fibrosis in Salivary Glands. Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs) Contralateral Neck Recurrence Rates in Head and Neck Carcinomas after Primary Surgery, Bilateral Neck Dissection, a Pathologically Negative Contralateral Neck, and Adjuvant Ipsilateral Neck Radiation Phase II Trial of Proton Re-Irradiation+/-Chemotherapy in Previously Irradiated Recurrent Head/Neck Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1